{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:44:37Z","timestamp":1792104277503,"version":"4.4.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12942-0","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:56:03Z","timestamp":1792101363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell-free DNA methylation markers in the diagnosis of hepatitis B virus-related- hepatocellular carcinoma: a review"],"prefix":"10.1007","volume":"53","author":[{"given":"Serge Theophile","family":"Soubeiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoul Karim","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine","family":"Ilboudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendkuuni Florencia","family":"Djigma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Simpore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"12942_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.livres.2024.05.004","volume":"8","author":"W Abdelhamed","year":"2024","unstructured":"Abdelhamed W, El-Kassas M (2024) Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do. Liver Res 8:83\u201390. https:\/\/doi.org\/10.1016\/j.livres.2024.05.004","journal-title":"Liver Res"},{"key":"12942_CR2","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1002\/hep4.1974","volume":"6","author":"AS Duberg","year":"2022","unstructured":"Duberg AS, Lybeck C, F\u00e4lt A, Montgomery S, Aleman S (2022) Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study. Hepatol Commun 6:2418\u20132430. https:\/\/doi.org\/10.1002\/hep4.1974","journal-title":"Hepatol Commun"},{"issue":"1","key":"12942_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2021-324915","volume":"72","author":"A Vitale","year":"2023","unstructured":"Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E (2023) Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002\u20132033: the ITA. LI. CA database. Gut 72(1):141\u2013152. https:\/\/doi.org\/10.1136\/gutjnl-2021-324915","journal-title":"Gut"},{"key":"12942_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.17998\/jlc.2024.03.13","volume":"24","author":"DY Kim","year":"2024","unstructured":"Kim DY (2024) Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide. J Liver Cancer 24:62\u201370. https:\/\/doi.org\/10.17998\/jlc.2024.03.13","journal-title":"J Liver Cancer"},{"key":"12942_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","volume":"101","author":"C Ayuso","year":"2018","unstructured":"Ayuso C, Rimola J, Vilana R, Burrel M, Darnell A, Garc\u00eda-Criado \u00c1, Bianchi L, Belmonte E, Caparroz C, Barrufet M, Bruix J, Br\u00fa C (2018) Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol 101:72\u201381. https:\/\/doi.org\/10.1016\/j.ejrad.2018.01.025","journal-title":"Eur J Radiol"},{"key":"12942_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1159\/000509424","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, Bie P, Liu L, Wen T, Han G, Wang M, Liu R, Lu L, Ren Z, Chen M, Zeng Z, Liang P, Liang C, Chen M, Yan F, Wang W, Ji Y, Yun J, Cai D, Chen Y, Cheng W, Cheng S, Dai C, Guo W, Hua B, Huang X, Jia W, Li Y, Li Y, Liang J, Liu T, Lv G, Mao Y, Peng T, Ren W, Shi H, Shi G, Tao K, Wang W, Wang X, Wang Z, Xiang B, Xing B, Xu J, Yang J, Yang J, Yang Y, Yang Y, Ye S, Yin Z, Zhang B, Zhang B, Zhang L, Zhang S, Zhang T, Zhao Y, Zheng H, Zhu J, Zhu K, Liu R, Shi Y, Xiao Y, Dai Z, Teng G, Cai J, Wang W, Cai X, Li Q, Shen F, Qin S, Dong J, Fan J (2020) Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer 9:682\u2013720. https:\/\/doi.org\/10.1159\/000509424","journal-title":"Liver Cancer"},{"key":"12942_CR7","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.21037\/jgo.2020.02.08","volume":"12","author":"H Samant","year":"2021","unstructured":"Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12:S361\u2013s373. https:\/\/doi.org\/10.21037\/jgo.2020.02.08","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"12942_CR8","first-page":"298","volume":"26","author":"D Moris","year":"2021","unstructured":"Moris D (2021) A farewell to Barcelona Clinic Liver Cancer (BCLC) classification for hepatocellular carcinoma. J buon 26(2):298\u2013302","journal-title":"J buon"},{"key":"12942_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DT (2022) Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol 28:216\u2013229. https:\/\/doi.org\/10.3748\/wjg.v28.i2.216","journal-title":"World J Gastroenterol"},{"key":"12942_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12876-021-01714-8","volume":"21","author":"J Lewin","year":"2021","unstructured":"Lewin J, Kottwitz D, Aoyama J, deVos T, Garces J, Hasinger O, Kasielke S, Knaust F, Rathi P, Rausch S, Weiss G, Zipprich A, Mena E, Fong T-L (2021) Plasma cell-free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case-control study. BMC Gastroenterol 21:136. https:\/\/doi.org\/10.1186\/s12876-021-01714-8","journal-title":"BMC Gastroenterol"},{"key":"12942_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.21147\/j.issn.1000-9604.2023.01.06","volume":"35","author":"M Cao","year":"2023","unstructured":"Cao M, Shi J, Xia C, Li H, Cai W, Qi X, Dai C, Chen W (2023) Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial. Chin J Cancer Res 35:58\u201365. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.01.06","journal-title":"Chin J Cancer Res"},{"key":"12942_CR12","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.3748\/wjg.v19.i20.3143","volume":"19","author":"K Chen","year":"2013","unstructured":"Chen K, Zhang H, Zhang LN, Ju SQ, Qi J, Huang DF, Li F, Wei Q, Zhang J (2013) Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma. World J Gastroenterol 19:3143\u20133149. https:\/\/doi.org\/10.3748\/wjg.v19.i20.3143","journal-title":"World J Gastroenterol"},{"key":"12942_CR13","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","volume":"154","author":"K Tzartzeva","year":"2018","unstructured":"Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, Waljee AK, Singal AG (2018) Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology 154:1706\u20131718e1. https:\/\/doi.org\/10.1053\/j.gastro.2018.01.064","journal-title":"Gastroenterology"},{"key":"12942_CR14","doi-asserted-by":"publisher","first-page":"e27673","DOI":"10.1097\/md.0000000000027673","volume":"100","author":"J-M Zhou","year":"2021","unstructured":"Zhou J-M, Wang T, Zhang K-H (2021) AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis. Medicine 100:e27673. https:\/\/doi.org\/10.1097\/md.0000000000027673","journal-title":"Medicine"},{"key":"12942_CR15","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.cgh.2020.08.065","volume":"19","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Ramasubramanian TS, Bhattacharya A, Olson MC, Edwards VD, Roberts LR, Kisiel JB, Reddy KR, Lidgard GP, Johnson SC, Bruinsma JJ (2021) A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 19:2597\u20132605e4. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.065","journal-title":"Clin Gastroenterol Hepatol"},{"key":"12942_CR16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cam4.2799","volume":"9","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Chen P, Xie H, Cao P (2020) Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis. Cancer Med 9:1349\u20131364. https:\/\/doi.org\/10.1002\/cam4.2799","journal-title":"Cancer Med"},{"key":"12942_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","volume":"20","author":"B Luo","year":"2022","unstructured":"Luo B, Ma F, Liu H, Hu J, Rao L, Liu C, Jiang Y, Kuangzeng S, Lin X, Wang C, Lei Y, Si Z, Chen G, Zhou N, Liang C, Jiang F, Liu F, Dai W, Liu W, Gao Y, Li Z, Li X, Zhou G, Li B, Zhang Z, Nian W, Luo L, Liu X (2022) Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Med 20:8. https:\/\/doi.org\/10.1186\/s12916-021-02201-3","journal-title":"BMC Med"},{"key":"12942_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.14744\/hf.2022.2022.0021","volume":"3","author":"P Telli","year":"2022","unstructured":"Telli P, Ozturk NB, Hakan MT, Cavus B, Ormeci AC, Yakut A, Senkal V, Imanov Z, Poyanli A, Isik EG, Demir K, Besisik F, Kaymakoglu S, Yaylim I, Akyuz F (2022) Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis. Hepatol Forum 3:77\u201381. https:\/\/doi.org\/10.14744\/hf.2022.2022.0021","journal-title":"Hepatol Forum"},{"issue":"18","key":"12942_CR19","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.3390\/ijms22189858","volume":"22","author":"D Zhang","year":"2021","unstructured":"Zhang D, Guo S, Schrodi SJ (2021) Mechanisms of DNA Methylation in Virus-Host Interaction in Hepatitis B Infection: Pathogenesis and Oncogenetic Properties. Int J Mol Sci 22(18):9858. https:\/\/doi.org\/10.3390\/ijms22189858","journal-title":"Int J Mol Sci"},{"key":"12942_CR20","doi-asserted-by":"publisher","first-page":"2421231","DOI":"10.1080\/21505594.2024.2421231","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z, Xie Y, Li M (2024) Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence 15:2421231. https:\/\/doi.org\/10.1080\/21505594.2024.2421231","journal-title":"Virulence"},{"key":"12942_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jncc.2024.12.007","volume":"5","author":"N Li","year":"2025","unstructured":"Li N, Song K, Chen H, Dai M (2025) Advance and challenge of DNA methylation as cancer biomarkers for risk stratification, screening and early detection. J Natl Cancer Cent 5:108\u2013112. https:\/\/doi.org\/10.1016\/j.jncc.2024.12.007","journal-title":"J Natl Cancer Cent"},{"key":"12942_CR22","doi-asserted-by":"publisher","unstructured":"Rendek T, Pos O, Duranova T, Saade R, Budis J, Repiska V, Szemes T (2024) Current Challenges of Methylation-Based Liquid Biopsies in Cancer Diagnostics. Cancers (Basel) 16. https:\/\/doi.org\/10.3390\/cancers16112001","DOI":"10.3390\/cancers16112001"},{"key":"12942_CR23","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1002\/mco2.766","volume":"5","author":"L Li","year":"2024","unstructured":"Li L, Sun Y (2024) Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges. MedComm (2020) 5:e766. https:\/\/doi.org\/10.1002\/mco2.766","journal-title":"MedComm (2020)"},{"key":"12942_CR24","doi-asserted-by":"publisher","unstructured":"Arisi MF, Dotan E, Fernandez SV (2022) Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23084441","DOI":"10.3390\/ijms23084441"},{"key":"12942_CR25","doi-asserted-by":"publisher","unstructured":"Wen X, Pu H, Liu Q, Guo Z, Luo D (2022) Circulating Tumor DNA-A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14246025","DOI":"10.3390\/cancers14246025"},{"key":"12942_CR26","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","volume":"33","author":"J Pascual","year":"2022","unstructured":"Pascual J, Attard G, Bidard FC, Curigliano G, De Mattos-Arruda L, Diehn M, Italiano A, Lindberg J, Merker JD, Montagut C, Normanno N, Pantel K, Pentheroudakis G, Popat S, Reis-Filho JS, Tie J, Seoane J, Tarazona N, Yoshino T, Turner NC (2022) ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Ann Oncol 33:750\u2013768. https:\/\/doi.org\/10.1016\/j.annonc.2022.05.520","journal-title":"Ann Oncol"},{"key":"12942_CR27","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/s41388-025-03624-5","volume":"44","author":"H Pharo","year":"2025","unstructured":"Pharo H, Vedeld HM, Sjurgard IV, Pinto R, Lind GE (2025) From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies. Oncogene 44:4814\u20134831. https:\/\/doi.org\/10.1038\/s41388-025-03624-5","journal-title":"Oncogene"},{"key":"12942_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13046-025-03398-4","volume":"44","author":"K Pantel","year":"2025","unstructured":"Pantel K, Alix-Panabi\u00e8res C, Hofman P, Stoecklein NH, Lu YJ, Lianidou E, Giacomini P, Koch C, de Jager V, Deans ZC, Fairley J, Patton SJ, Toledo RA, Schuuring E, Heitzer E, Hendrix A, Ricklefs FL, Thakur BK, von Bubnoff N, Pierga JY, Gebhardt C, Andersen CL, Fijneman R, Malats N, Hallermayr A, Chelala C, Joosse SA, Ciliberto G (2025) Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS). J Exp Clin Cancer Res 44:156. https:\/\/doi.org\/10.1186\/s13046-025-03398-4","journal-title":"J Exp Clin Cancer Res"},{"key":"12942_CR29","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1038\/s41467-021-22901-x","volume":"12","author":"C Caggiano","year":"2021","unstructured":"Caggiano C, Celona B, Garton F, Mefford J, Black BL, Henderson R, Lomen-Hoerth C, Dahl A, Zaitlen N (2021) Comprehensive cell type decomposition of circulating cell-free DNA with CelFiE. Nat Commun 12:2717. https:\/\/doi.org\/10.1038\/s41467-021-22901-x","journal-title":"Nat Commun"},{"key":"12942_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/biom14040498","volume":"14","author":"M Sorbini","year":"2024","unstructured":"Sorbini M, Carradori T, Togliatto GM, Vaisitti T, Deaglio S (2024) Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients\u2019 Care. Biomolecules 14:498. https:\/\/doi.org\/10.3390\/biom14040498","journal-title":"Biomolecules"},{"key":"12942_CR31","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/brv.12413","volume":"93","author":"J Aucamp","year":"2018","unstructured":"Aucamp J, Bronkhorst AJ, Badenhorst CPS, Pretorius PJ (2018) The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature. Biol Rev Camb Philos Soc 93:1649\u20131683. https:\/\/doi.org\/10.1111\/brv.12413","journal-title":"Biol Rev Camb Philos Soc"},{"key":"12942_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11357-022-00590-8","volume":"45","author":"L Kananen","year":"2023","unstructured":"Kananen L, Hurme M, B\u00fcrkle A, Moreno-Villanueva M, Bernhardt J, Debacq-Chainiaux F, Grubeck-Loebenstein B, Malavolta M, Basso A, Piacenza F, Collino S, Gonos ES, Sikora E, Gradinaru D, Jansen EHJM, Doll\u00e9 MET, Salmon M, Stuetz W, Weber D, Grune T, Breusing N, Simm A, Capri M, Franceschi C, Slagboom E, Talbot D, Libert C, Raitanen J, Koskinen S, H\u00e4rk\u00e4nen T, Stenholm S, Ala-Korpela M, Lehtim\u00e4ki T, Raitakari OT, Ukkola O, K\u00e4h\u00f6nen M, Jylh\u00e4 M, Jylh\u00e4v\u00e4 J (2023) Circulating cell-free DNA in health and disease \u2014 the relationship to health behaviours, ageing phenotypes and metabolomics. GeroScience 45:85\u2013103. https:\/\/doi.org\/10.1007\/s11357-022-00590-8","journal-title":"GeroScience"},{"key":"12942_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1586\/14737159.2013.845088","volume":"13","author":"DM Marzese","year":"2013","unstructured":"Marzese DM, Hirose H, Hoon DS (2013) Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. Expert Rev Mol Diagn 13:827\u2013844. https:\/\/doi.org\/10.1586\/14737159.2013.845088","journal-title":"Expert Rev Mol Diagn"},{"key":"12942_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-023-01910-y","volume":"23","author":"K Yasui","year":"2024","unstructured":"Yasui K, Toshima T, Inada R, Umeda Y, Yano S, Tanioka H, Nyuya A, Fujiwara T, Yamada T, Naomoto Y, Goel A, Nagasaka T (2024) Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles. Mol Cancer 23:1. https:\/\/doi.org\/10.1186\/s12943-023-01910-y","journal-title":"Mol Cancer"},{"key":"12942_CR35","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.1703577114","volume":"114","author":"X Hao","year":"2017","unstructured":"Hao X, Luo H, Krawczyk M, Wei W, Wang W, Wang J, Flagg K, Hou J, Zhang H, Yi S, Jafari M, Lin D, Chung C, Caughey BA, Li G, Dhar D, Shi W, Zheng L, Hou R, Zhu J, Zhao L, Fu X, Zhang E, Zhang C, Zhu JK, Karin M, Xu RH, Zhang K (2017) DNA methylation markers for diagnosis and prognosis of common cancers. Proc Natl Acad Sci U S A 114:7414\u20137419. https:\/\/doi.org\/10.1073\/pnas.1703577114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12942_CR36","volume-title":"Epigenetics","author":"AK Ewelina","year":"2023","unstructured":"Ewelina AK (2023) DNA Methylation in Cancer Epigenetics. In: Tao H (ed) Epigenetics. IntechOpen, Rijeka. Ch. 3"},{"key":"12942_CR37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12015-016-9672-6","volume":"12","author":"L Song","year":"2016","unstructured":"Song L, Li Y (2016) The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis. Stem Cell Rev Rep 12:573\u2013583. https:\/\/doi.org\/10.1007\/s12015-016-9672-6","journal-title":"Stem Cell Rev Rep"},{"key":"12942_CR38","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1038\/s41598-024-53754-1","volume":"14","author":"T Dra\u0161kovi\u010d","year":"2024","unstructured":"Dra\u0161kovi\u010d T, Hauptman N (2024) Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases. Sci Rep 14:3095. https:\/\/doi.org\/10.1038\/s41598-024-53754-1","journal-title":"Sci Rep"},{"key":"12942_CR39","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1327","author":"B Wang","year":"2024","unstructured":"Wang B, Wang M, Lin Y, Zhao J, Gu H, Li X (2024) Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management. Clin Chem Lab Med. https:\/\/doi.org\/10.1515\/cclm-2023-1327","journal-title":"Clin Chem Lab Med"},{"key":"12942_CR40","doi-asserted-by":"publisher","unstructured":"Mocan T, Sim\u00e3o AL, Castro RE, Rodrigues CMP, S\u0142omka A, Wang B, Strassburg C, W\u00f6hler A, Willms AG, Kornek M (2020) Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning? J Clin Med 9. https:\/\/doi.org\/10.3390\/jcm9051541","DOI":"10.3390\/jcm9051541"},{"key":"12942_CR41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.molmed.2020.12.011","volume":"27","author":"H Luo","year":"2021","unstructured":"Luo H, Wei W, Ye Z, Zheng J, Xu RH (2021) Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA. Trends Mol Med 27:482\u2013500. https:\/\/doi.org\/10.1016\/j.molmed.2020.12.011","journal-title":"Trends Mol Med"},{"key":"12942_CR42","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/1878-0261.12978","volume":"15","author":"E Lianidou","year":"2021","unstructured":"Lianidou E (2021) Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook. Mol Oncol 15:1683\u20131700. https:\/\/doi.org\/10.1002\/1878-0261.12978","journal-title":"Mol Oncol"},{"key":"12942_CR43","first-page":"6462","volume":"11","author":"Y An","year":"2019","unstructured":"An Y, Guan Y, Xu Y, Han Y, Wu C, Bao C, Zhou B, Wang H, Zhang M, Liu W, Qiu L, Han Z, Chen Y, Xia X, Wang J, Liu Z, Huang W, Yi X, Huang J (2019) The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma. Am J Transl Res 11:6462\u20136474","journal-title":"Am J Transl Res"},{"key":"12942_CR44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41422-020-00457-7","volume":"31","author":"L Chen","year":"2021","unstructured":"Chen L, Abou-Alfa GK, Zheng B, Liu J-F, Bai J, Du L-T, Qian Y-S, Fan R, Liu X-L, Wu L, Hou J-L, Wang H-Y, The PreCar Team (2021) Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients. Cell Res 31:589\u2013592. https:\/\/doi.org\/10.1038\/s41422-020-00457-7","journal-title":"Cell Res"},{"key":"12942_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-023-01872-1","volume":"22","author":"S-C Kim","year":"2023","unstructured":"Kim S-C, Kim D-W, Cho EJ, Lee J-Y, Kim J, Kwon C, Kim-Ha J, Hong SK, Choi Y, Yi N-J, Lee K-W, Suh K-S, Kim W, Kim W, Kim H, Kim YJ, Yoon J-H, Yu SJ, Kim Y-J (2023) A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma. Mol Cancer 22:164. https:\/\/doi.org\/10.1186\/s12943-023-01872-1","journal-title":"Mol Cancer"},{"key":"12942_CR46","doi-asserted-by":"publisher","first-page":"6406","DOI":"10.18632\/oncotarget.14115","volume":"8","author":"CY Lu","year":"2017","unstructured":"Lu CY, Chen SY, Peng HL, Kan PY, Chang WC, Yen CJ (2017) Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma. Oncotarget 8:6406\u20136418. https:\/\/doi.org\/10.18632\/oncotarget.14115","journal-title":"Oncotarget"},{"key":"12942_CR47","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.gendis.2022.04.003","volume":"10","author":"Q Yan","year":"2023","unstructured":"Yan Q, Sun Y-s, An R, Liu F, Fang Q, Wang Z, Xu T, Chen L, Du J (2023) Application and progress of the detection technologies in hepatocellular carcinoma. Genes Dis 10:1857\u20131869. https:\/\/doi.org\/10.1016\/j.gendis.2022.04.003","journal-title":"Genes Dis"},{"key":"12942_CR48","doi-asserted-by":"publisher","first-page":"e45784","DOI":"10.7759\/cureus.45784","volume":"15","author":"P Bittla","year":"2023","unstructured":"Bittla P, Kaur S, Sojitra V, Zahra A, Hutchinson J, Folawemi O, Khan S (2023) Exploring Circulating Tumor DNA (CtDNA) and Its Role in Early Detection of Cancer: A Systematic Review. Cureus 15:e45784. https:\/\/doi.org\/10.7759\/cureus.45784","journal-title":"Cureus"},{"key":"12942_CR49","doi-asserted-by":"publisher","first-page":"e15172","DOI":"10.1200\/JCO.2023.41.16_suppl.e15172","volume":"41","author":"H Wang","year":"2023","unstructured":"Wang H, Pan X, Wang L, Li C, Ma C, Yu S, Meng F, Liu J, Liu L, Cao Z (2023) Circulating tumor DNA methylation marker-based minimal residual diseases detection and recurrence monitoring of cancer. J Clin Oncol 41:e15172\u2013e15172. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.e15172","journal-title":"J Clin Oncol"},{"key":"12942_CR50","doi-asserted-by":"publisher","first-page":"112960","DOI":"10.1016\/j.ejca.2023.112960","volume":"191","author":"S Fu","year":"2023","unstructured":"Fu S, Debes JD, Boonstra A (2023) DNA methylation markers in the detection of hepatocellular carcinoma. Eur J Cancer 191:112960. https:\/\/doi.org\/10.1016\/j.ejca.2023.112960","journal-title":"Eur J Cancer"},{"key":"12942_CR51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2024.01.001","volume":"42","author":"S Heeke","year":"2024","unstructured":"Heeke S, Gay CM, Estecio MR, Tran H, Morris BB, Zhang B, Tang X, Raso MG, Rocha P, Lai S, Arriola E, Hofman P, Hofman V, Kopparapu P, Lovly CM, Concannon K, De Sousa LG, Lewis WE, Kondo K, Heymach JV (2024) Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes. Cancer Cell 42:225\u2013237e5. https:\/\/doi.org\/10.1016\/j.ccell.2024.01.001","journal-title":"Cancer Cell"},{"key":"12942_CR52","doi-asserted-by":"publisher","first-page":"300060521992962","DOI":"10.1177\/0300060521992962","volume":"49","author":"J Wang","year":"2021","unstructured":"Wang J, Yang L, Diao Y, Liu J, Li J, Li R, Zheng L, Zhang K, Ma Y, Hao X (2021) Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR. J Int Med Res 49:300060521992962. https:\/\/doi.org\/10.1177\/0300060521992962","journal-title":"J Int Med Res"},{"key":"12942_CR53","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/cancers15153959","volume":"15","author":"M Borg","year":"2023","unstructured":"Borg M, Wen SWC, Andersen RF, Timm S, Hansen TF, Hilberg O (2023) Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis. Cancers 15:3959. https:\/\/doi.org\/10.3390\/cancers15153959","journal-title":"Cancers"},{"key":"12942_CR54","doi-asserted-by":"publisher","first-page":"943253","DOI":"10.3389\/fonc.2022.943253","volume":"12","author":"E S\u00e1nchez-Herrero","year":"2022","unstructured":"S\u00e1nchez-Herrero E, Serna-Blasco R, Robado de Lope L, Gonz\u00e1lez-Rumayor V, Romero A, Provencio M (2022) Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis. Front Oncol 12:943253. https:\/\/doi.org\/10.3389\/fonc.2022.943253","journal-title":"Front Oncol"},{"key":"12942_CR55","doi-asserted-by":"publisher","unstructured":"Turabi K, Klute K, Radhakrishnan P (2024) Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies. Cancers (Basel) 16. https:\/\/doi.org\/10.3390\/cancers16132432","DOI":"10.3390\/cancers16132432"},{"key":"12942_CR56","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/erc-15-0369","volume":"23","author":"K Warton","year":"2016","unstructured":"Warton K, Mahon KL, Samimi G (2016) Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocrine-related Cancer 23:R157\u2013R171. https:\/\/doi.org\/10.1530\/erc-15-0369","journal-title":"Endocrine-related Cancer"},{"key":"12942_CR57","doi-asserted-by":"publisher","unstructured":"Kumar S, Chinnusamy V, Mohapatra T (2018) Epigenetics of Modified DNA Bases: 5-Methylcytosine and Beyond. Front Genet 9. https:\/\/doi.org\/10.3389\/fgene.2018.00640","DOI":"10.3389\/fgene.2018.00640"},{"key":"12942_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-031-11454-0_3","volume":"1389","author":"S Tajima","year":"2022","unstructured":"Tajima S, Suetake I, Takeshita K, Nakagawa A, Kimura H, Song J (2022) Domain Structure of the Dnmt1, Dnmt3a, and Dnmt3b DNA Methyltransferases. Adv Exp Med Biol 1389:45\u201368. https:\/\/doi.org\/10.1007\/978-3-031-11454-0_3","journal-title":"Adv Exp Med Biol"},{"key":"12942_CR59","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbagrm.2012.02.014","volume":"1819","author":"R Chatterjee","year":"2012","unstructured":"Chatterjee R, Vinson C (2012) CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim Biophys Acta 1819:763\u2013770. https:\/\/doi.org\/10.1016\/j.bbagrm.2012.02.014","journal-title":"Biochim Biophys Acta"},{"key":"12942_CR60","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1017\/erm.2022.38","volume":"25","author":"WF Low","year":"2022","unstructured":"Low WF, Ngeow YF, Chook JB, Tee KK, Ong S-K, Peh SC, Bong JJ, Mohamed R (2022) Hepatitis B virus DNA methylation and its potential role in chronic hepatitis B. Expert Rev Mol Med 25:e11. https:\/\/doi.org\/10.1017\/erm.2022.38","journal-title":"Expert Rev Mol Med"},{"key":"12942_CR61","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.1038\/srep10478","volume":"5","author":"S Jain","year":"2015","unstructured":"Jain S, Chang T-T, Chen S, Boldbaatar B, Clemens A, Lin SY, Yan R, Hu C-T, Guo H, Block TM, Song W, Su Y-H (2015) Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues. Sci Rep 5:10478. https:\/\/doi.org\/10.1038\/srep10478","journal-title":"Sci Rep"},{"key":"12942_CR62","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/655398","volume":"202","author":"P Kaur","year":"2010","unstructured":"Kaur P, Paliwal A, Durantel D, Hainaut P, Scoazec J-Y, Zoulim F, Chemin I, Herceg Z (2010) DNA Methylation of Hepatitis B Virus (HBV) Genome Associated with the Development of Hepatocellular Carcinoma and Occult HBV Infection. J Infect Dis 202:700\u2013704. https:\/\/doi.org\/10.1086\/655398","journal-title":"J Infect Dis"},{"key":"12942_CR63","unstructured":"Joyce C, Rayi A, Kasi A (2023) Tumor-suppressor genes. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"12942_CR64","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1002\/ctd2.279","volume":"4","author":"S Sonar","year":"2024","unstructured":"Sonar S, Nyahatkar S, Kalele K, Adhikari MD (2024) Role of DNA methylation in cancer development and its clinical applications. Clin Translational Discovery 4:e279. https:\/\/doi.org\/10.1002\/ctd2.279","journal-title":"Clin Translational Discovery"},{"key":"12942_CR65","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3892\/ol.2014.2301","volume":"8","author":"Y Dong","year":"2014","unstructured":"Dong Y, Wang A (2014) Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review). Oncol Lett 8:963\u2013968. https:\/\/doi.org\/10.3892\/ol.2014.2301","journal-title":"Oncol Lett"},{"key":"12942_CR66","first-page":"65","volume":"20","author":"BK Oh","year":"2007","unstructured":"Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN (2007) DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med 20:65\u201373","journal-title":"Int J Mol Med"},{"key":"12942_CR67","doi-asserted-by":"publisher","first-page":"20545","DOI":"10.1074\/jbc.M112.359760","volume":"287","author":"V Pandey","year":"2012","unstructured":"Pandey V, Kumar V (2012) HBx Protein of Hepatitis B Virus Promotes Reinitiation of DNA Replication by Regulating Expression and Intracellular Stability of Replication Licensing Factor CDC6*. J Biol Chem 287:20545\u201320554. https:\/\/doi.org\/10.1074\/jbc.M112.359760","journal-title":"J Biol Chem"},{"key":"12942_CR68","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/onc.2011.255","volume":"31","author":"A Arzumanyan","year":"2012","unstructured":"Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z, Feitelson MA (2012) Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene 31:563\u2013572. https:\/\/doi.org\/10.1038\/onc.2011.255","journal-title":"Oncogene"},{"key":"12942_CR69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/mmr.2015.4545","volume":"13","author":"X Fu","year":"2016","unstructured":"Fu X, Song X, Li Y, Tan D, Liu G (2016) Hepatitis B virus X protein upregulates DNA methyltransferase 3A\/3B and enhances SOCS-1CpG island methylation. Mol Med Rep 13:301\u2013308. https:\/\/doi.org\/10.3892\/mmr.2015.4545","journal-title":"Mol Med Rep"},{"key":"12942_CR70","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3892\/or.2013.2848","volume":"31","author":"X Qiu","year":"2014","unstructured":"Qiu X, Zhang L, Lu S, Song Y, Lao Y, Hu J, Fan H (2014) Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation. Oncol Rep 31:202\u2013208. https:\/\/doi.org\/10.3892\/or.2013.2848","journal-title":"Oncol Rep"},{"key":"12942_CR71","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1128\/mcb.00205-13","volume":"33","author":"Y Tian","year":"2013","unstructured":"Tian Y, Yang W, Song J, Wu Y, Ni B (2013) Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol 33:2810\u20132816. https:\/\/doi.org\/10.1128\/mcb.00205-13","journal-title":"Mol Cell Biol"},{"key":"12942_CR72","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/jcm10081715","volume":"10","author":"MB Zeisel","year":"2021","unstructured":"Zeisel MB, Guerrieri F, Levrero M (2021) Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma. J Clin Med 10:1715","journal-title":"J Clin Med"},{"key":"12942_CR73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jhep.2008.10.019","volume":"50","author":"DL Zheng","year":"2009","unstructured":"Zheng DL, Zhang L, Cheng N, Xu X, Deng Q, Teng XM, Wang KS, Zhang X, Huang J, Han ZG (2009) Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol 50:377\u2013387. https:\/\/doi.org\/10.1016\/j.jhep.2008.10.019","journal-title":"J Hepatol"},{"key":"12942_CR74","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.2217\/fon-2022-1218","volume":"18","author":"TH Phan","year":"2022","unstructured":"Phan TH, Chi Nguyen VT, Thi Pham TT, Nguyen V-C, Ho TD, Quynh Pham TM, Tran T-H, Nguyen TD, Khang Le ND, Nguyen T-H, Duong M-L, Bach H-PT, Kim V-V, Pham T-A, Nguyen BT, Vo Nguyen TN, Nguyen TD, Bieu Phu DT, Huu Phan BH, Duy-Sinh N, Truong D-K, Thi Do T-T, Giang H, Nguyen H-N, Phan M-D, Tran LS (2022) Circulating DNA Methylation Profile Improves the Accuracy of Serum Biomarkers for the Detection Of Nonmetastatic Hepatocellular Carcinoma. Future Oncol 18:4399\u20134413. https:\/\/doi.org\/10.2217\/fon-2022-1218","journal-title":"Future Oncol"},{"key":"12942_CR75","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2019.30","author":"BA Banini","year":"2019","unstructured":"Banini BA, Sanyal AJ (2019) The use of cell free DNA in the diagnosis of HCC. Hepatoma Res. 5https:\/\/doi.org\/10.20517\/2394-5079.2019.30","journal-title":"Hepatoma Res"},{"key":"12942_CR76","doi-asserted-by":"publisher","first-page":"101448","DOI":"10.1016\/j.jceh.2024.101448","volume":"14","author":"AG Singal","year":"2024","unstructured":"Singal AG, Ng M, Kulkarni A (2024) Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision. J Clin Exp Hepatol 14:101448. https:\/\/doi.org\/10.1016\/j.jceh.2024.101448","journal-title":"J Clin Exp Hepatol"},{"key":"12942_CR77","doi-asserted-by":"publisher","first-page":"e0321736","DOI":"10.1371\/journal.pone.0321736","volume":"20","author":"R Hu","year":"2025","unstructured":"Hu R, Tran B, Li S, Stackpole ML, Zeng W, Zhou Y, Melehy A, Sadeghi S, Finn RS, Zhou XJ, Li W, Agopian VG (2025) Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylation. PLoS ONE 20:e0321736. https:\/\/doi.org\/10.1371\/journal.pone.0321736","journal-title":"PLoS ONE"},{"key":"12942_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10238-025-01599-x","volume":"25","author":"CY Lu","year":"2025","unstructured":"Lu CY, Tsai KF, Yen CJ, Hsieh CJ, Peng PJ, Huang SC, Chuang MR, Chu CJ (2025) Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clin Exp Med 25:83. https:\/\/doi.org\/10.1007\/s10238-025-01599-x","journal-title":"Clin Exp Med"},{"key":"12942_CR79","doi-asserted-by":"publisher","unstructured":"Bettegowda C, Sausen M, Leary R, Kinde I, Wang Y, Agrawal N, Bartlett B, Wang H, Luber B, Alani R (2014) Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med 6:224ra24. https:\/\/doi.org\/10.1126\/scitranslmed.3007094","DOI":"10.1126\/scitranslmed.3007094"},{"key":"12942_CR80","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jmoldx.2021.06.003","volume":"23","author":"Z Meng","year":"2021","unstructured":"Meng Z, Ren Q, Zhong G, Li S, Chen Y, Wu W, Feng Y, Mao M, Zhang F, Long G (2021) Noninvasive Detection of Hepatocellular Carcinoma with Circulating Tumor DNA Features and \u03b1-Fetoprotein. J Mol Diagn 23:1174\u20131184. https:\/\/doi.org\/10.1016\/j.jmoldx.2021.06.003","journal-title":"J Mol Diagn"},{"key":"12942_CR81","doi-asserted-by":"publisher","first-page":"eaan2415","DOI":"10.1126\/scitranslmed.aan2415","volume":"9","author":"J Phallen","year":"2017","unstructured":"Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E (2017) Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med 9:eaan2415. https:\/\/doi.org\/10.1126\/scitranslmed.aan2415","journal-title":"Sci Transl Med"},{"key":"12942_CR82","doi-asserted-by":"publisher","first-page":"eaaw3616","DOI":"10.1126\/science.aaw3616","volume":"372","author":"YD Lo","year":"2021","unstructured":"Lo YD, Han DS, Jiang P, Chiu RW (2021) Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science 372:eaaw3616. https:\/\/www.science.org\/doi\/https:\/\/doi.org\/10.1126\/science.aaw3616","journal-title":"Science"},{"key":"12942_CR83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","volume":"6","author":"D Roy","year":"2020","unstructured":"Roy D, Tiirikainen M (2020) Diagnostic power of DNA methylation classifiers for early detection of cancer. Trends cancer 6:78\u201381. https:\/\/doi.org\/10.1016\/j.trecan.2019.12.006","journal-title":"Trends cancer"},{"key":"12942_CR84","doi-asserted-by":"publisher","unstructured":"Xu X, Guo Y, Liu M, Hu Y, Li S (2024) Advancements in the clinical application of gene methylation for early cancer detection. Front Epigenetics Epigenomics Volume 2\u20132024. https:\/\/doi.org\/10.3389\/freae.2024.1430294","DOI":"10.3389\/freae.2024.1430294"},{"key":"12942_CR85","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/mc.70101","volume":"65","author":"J Zhao","year":"2026","unstructured":"Zhao J, Shen S, Zhang J, Xu Y, Peng J, Gao H, Li L (2026) Whole-Genome Bisulfite Sequencing Identifies Blood-Based DNA Methylation Biomarker for Hepatocellular Carcinoma. Mol Carcinog 65:603\u2013614. https:\/\/doi.org\/10.1002\/mc.70101","journal-title":"Mol Carcinog"},{"key":"12942_CR86","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/xcs.0000000000001792","volume":"242","author":"S Javanshir","year":"2026","unstructured":"Javanshir S, Angeli-Pahim I, Iyengar P, Chambers A, Smarandache IM, Ganguli R, Hughes S, Sahin I, Duarte S, Zarrinpar A (2026) Quantification of DNA Methylation for Diagnosis and Monitoring of Hepatocellular Carcinoma. J Am Coll Surg 242:934\u2013946. https:\/\/doi.org\/10.1097\/xcs.0000000000001792","journal-title":"J Am Coll Surg"},{"key":"12942_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1868-7083-6-30","volume":"6","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Xue F, Sun J, Guo S, Zhang H, Qiu B, Geng J, Gu J, Zhou X, Wang W, Zhang Z, Tang N, He Y, Yu J, Xia Q (2014) Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma. Clin Epigenetics 6:30. https:\/\/doi.org\/10.1186\/1868-7083-6-30","journal-title":"Clin Epigenetics"},{"key":"12942_CR88","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13148-025-01909-w","volume":"17","author":"J Sun","year":"2025","unstructured":"Sun J, Sun X, He W, Huang B, Feng W, Han Z, Ruan R, Pan Y, Zhu J, Li J, Zhong X, Ma M, Hu R, Lv M, Huang Q, Zhang W, Feng M, Yi J, Cui P, Zhou X (2025) A liquid biopsy approach detects HCC and identifies GJA4 as a potential biomarker for HBV-HCC via plasma cfDNA methylome profiling. Clin Epigenetics 17:98. https:\/\/doi.org\/10.1186\/s13148-025-01909-w","journal-title":"Clin Epigenetics"},{"key":"12942_CR89","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.cd-17-0716","volume":"7","author":"AA Chaudhuri","year":"2017","unstructured":"Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L (2017) Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer discov 7:1394\u20131403. https:\/\/doi.org\/10.1158\/2159-8290.cd-17-0716","journal-title":"Cancer discov"},{"key":"12942_CR90","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426\u2013437. https:\/\/doi.org\/10.1038\/nrc3066","journal-title":"Nat Rev Cancer"},{"key":"12942_CR91","doi-asserted-by":"publisher","first-page":"eabp8704","DOI":"10.1126\/scitranslmed.abp8704","volume":"14","author":"P Wang","year":"2022","unstructured":"Wang P, Song Q, Ren J, Zhang W, Wang Y, Zhou L, Wang D, Chen K, Jiang L, Zhang B, Chen W, Qu C, Zhao H, Jiao Y (2022) Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection. Sci Transl Med 14:eabp8704. https:\/\/doi.org\/10.1126\/scitranslmed.abp8704","journal-title":"Sci Transl Med"},{"key":"12942_CR92","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"B Sangro","year":"2025","unstructured":"European Association for the Study of the L, Sangro B, Argemi J, Ronot M, Paradis V, Meyer T, Mazzaferro V, Jepsen P, Golfieri R, Galle P, Dawson L, Reig M (2025) EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol 82:315\u2013374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028","journal-title":"J Hepatol"},{"key":"12942_CR93","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11901-025-00686-7","volume":"24","author":"JS Norman","year":"2025","unstructured":"Norman JS, Mehta N (2025) The Role of AFP-L3 and DCP Biomarkers in the Diagnosis and Management of Hepatocellular Carcinoma. Curr Hepatol Rep 24:16. https:\/\/doi.org\/10.1007\/s11901-025-00686-7","journal-title":"Curr Hepatol Rep"},{"key":"12942_CR94","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1073\/pnas.1819799116","volume":"116","author":"Q Qu","year":"2019","unstructured":"Qu Q, Wang Y, Wang P, Chen K, Wang M, Zeng H, Lu J, Song Q, Diplas BH, Tan D, Fan C, Guo Q, Zhu Z, Yin H, Jiang L, Chen X, Zhao H, He H, Wang Y, Li G, Bi X, Zhao X, Chen T, Tang H, Lu C, Wang D, Chen W, Zhou J, Zhao H, Cai J, Wang X, Wang S, Yan H, Zeng Y-X, Cavanee WK, Jiao Y (2019) Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy. Proc Natl Acad Sci 116:6308\u20136312. https:\/\/doi.org\/10.1073\/pnas.1819799116","journal-title":"Proc Natl Acad Sci"},{"key":"12942_CR95","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3126","volume":"46","author":"Y Totoki","year":"2014","unstructured":"Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S, Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, Walker K, Dahdouli M, Gotoh K, Nagae G, Gingras MC, Muzny DM, Ojima H, Shimada K, Midorikawa Y, Goss YA, Cotton R, Hayashi A, Shibahara J, Ishikawa S, Guiteau J, Tanaka M, Urushidate T, Ohashi S, Okada N, Doddapaneni H, Wang M, Zhu Y, Dinh H, Okusaka T, Kokudo N, Kosuge T, Takayama T, Fukayama M, Gibbs RA, Wheeler DA, Aburatani H, Shibata T (2014) Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet 46:1267\u20131273. https:\/\/doi.org\/10.1038\/ng.3126","journal-title":"Nat Genet"},{"key":"12942_CR96","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/j.gastro.2017.03.024","volume":"153","author":"W Zhang","year":"2017","unstructured":"Zhang W, He H, Zang M, Wu Q, Zhao H, Lu L-l, Ma P, Zheng H, Wang N, Zhang Y, He S, Chen X, Wu Z, Wang X, Cai J, Liu Z, Sun Z, Zeng Y-X, Qu C, Jiao Y (2017) Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma. Gastroenterology 153:249\u2013262e2. https:\/\/doi.org\/10.1053\/j.gastro.2017.03.024","journal-title":"Gastroenterology"},{"key":"12942_CR97","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1620\/tjem.232.187","volume":"232","author":"Y Yang","year":"2014","unstructured":"Yang Y, Fan YC, Gao S, Dou CY, Zhang JJ, Sun FK, Wang K (2014) Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Tohoku J Exp Med 232:187\u2013194. https:\/\/doi.org\/10.1620\/tjem.232.187","journal-title":"Tohoku J Exp Med"},{"key":"12942_CR98","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC, Bossuyt PM (2016) STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open 6:e012799. https:\/\/doi.org\/10.1136\/bmjopen-2016-012799","journal-title":"BMJ Open"},{"issue":"7","key":"12942_CR99","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/emermed-2019-208446","volume":"36","author":"MK Hall","year":"2019","unstructured":"Hall MK, Kea B, Wang R (2019) Recognising Bias in Studies of Diagnostic Tests Part 1: Patient Selection. Emerg Med J 36(7):431\u2013434. https:\/\/doi.org\/10.1136\/emermed-2019-208446","journal-title":"Emerg Med J"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12942-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12942-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:56:05Z","timestamp":1792101365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12942-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12942"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12942-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1722"}}